<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1810482/open_sms">We love to hear from our listeners. Send us a message.</a>BlueRock Therapeutics&apos; SVP Head of Development, Dr. Ahmed Enayetallah, joins Cell &amp; Gene: The Podcast Host, Erin Harris, to discuss the company&apos;s phase I clinical trial for Parkinson’s disease, which continues to show positive trends at 18 months. They cover the important role induced pluripotent stem cells&apos; (iPSCs) play in the trial, and they also discuss the company&apos;s investigational cell therapy, bemdaneprocel. Listen and subscribe so you never miss an episode!

CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.